CRH Medical Corp (NYSEARCA:CRHM) had its target price reduced by equities research analysts at Canaccord Genuity from $8.00 to $5.00 in a note issued to investors on Friday. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity’s price objective suggests a potential upside of 104.08% from the stock’s previous close.

CRHM has been the topic of several other reports. Zacks Investment Research upgraded CRH Medical Corp from a “sell” rating to a “hold” rating in a report on Tuesday, May 2nd. TD Securities cut CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. National Bank Financial upgraded CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a report on Friday. Royal Bank Of Canada upgraded CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a report on Friday, July 21st. Finally, Scotiabank upgraded CRH Medical Corp from a “sector perform” rating to a “sector outperform” rating in a report on Monday, July 24th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $8.13.

Shares of CRH Medical Corp (NYSEARCA:CRHM) opened at 2.45 on Friday. The firm’s 50-day moving average price is $4.77 and its 200-day moving average price is $6.37. CRH Medical Corp has a 12 month low of $2.45 and a 12 month high of $9.25.

ILLEGAL ACTIVITY WARNING: “CRH Medical Corp (CRHM) PT Lowered to $5.00 at Canaccord Genuity” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/06/crh-medical-corp-crhm-pt-lowered-to-5-00-at-canaccord-genuity.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CRHM. ARP Americas LLC boosted its position in CRH Medical Corp by 7.4% in the first quarter. ARP Americas LLC now owns 13,042 shares of the company’s stock worth $107,000 after buying an additional 900 shares in the last quarter. TD Asset Management Inc. boosted its position in CRH Medical Corp by 7.9% in the first quarter. TD Asset Management Inc. now owns 42,607 shares of the company’s stock worth $347,000 after buying an additional 3,124 shares in the last quarter. Hillsdale Investment Management Inc. boosted its position in CRH Medical Corp by 1.0% in the first quarter. Hillsdale Investment Management Inc. now owns 328,788 shares of the company’s stock worth $2,682,000 after buying an additional 3,200 shares in the last quarter. KCG Holdings Inc. boosted its position in CRH Medical Corp by 40.1% in the first quarter. KCG Holdings Inc. now owns 19,486 shares of the company’s stock worth $160,000 after buying an additional 5,579 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in CRH Medical Corp by 15,344.4% in the first quarter. Tower Research Capital LLC TRC now owns 13,900 shares of the company’s stock worth $114,000 after buying an additional 13,810 shares in the last quarter.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.